Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study

Clinical and Translational Radiation Oncology - Tập 42 - Trang 100654 - 2023
Cecilie Delphin Amdal1,2, Jon Magne Moan1, Einar Dale1, Ragnhild Sørum Falk2, Safora Johansen1,3, Kristin Bjordal2,4
1Department of Oncology, Oslo University Hospital, Oslo, Norway
2Research Support Services, Oslo University Hospital, Oslo, Norway
3Oslo Metropolitan University, Faculty of Health Sciences, Oslo, Norway
4University of Oslo, Faculty of Medicine, Oslo, Norway

Tài liệu tham khảo

Jeong, 2013, Re-irradiation of unresectable recurrent head and neck cancer: using Helical Tomotherapy as image-guided intensity-modulated radiotherapy, Radiation Oncol J, 31, 206, 10.3857/roj.2013.31.4.206 Schwartz, 1994, Synchronous and metachronous head and neck carcinomas, Cancer, 74, 1933, 10.1002/1097-0142(19941001)74:7<1933::AID-CNCR2820740718>3.0.CO;2-X Hoebers F, Heemsbergen W, Moor S, Lopez M, Klop M, Tesselaar M, et al. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity. Int J Radiat Oncol Biol Phys. 2011;81(3):e111-8. Wong, 2006, Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?, J Clin Oncol, 24, 2653, 10.1200/JCO.2005.05.3850 Vargo, 2012, Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck, Head Neck, 34, 1153, 10.1002/hed.21889 Chen, 2014, Functional and quality-of-life outcomes after reirradiation for head and neck cancer, Laryngoscope, 124, 1807, 10.1002/lary.24505 Kim, 2017, Reirradiation of head and neck cancer in the era of intensity-modulated radiotherapy: patient selection, practical aspects, and current evidence, Radiat Oncol J, 35, 1, 10.3857/roj.2017.00122 Strojan, 2015, Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate, Head Neck, 37, 134, 10.1002/hed.23542 Cacicedo, 2014, The role of re-irradiation of secondary and recurrent head and neck carcinomas. Is it a potentially curative treatment? A practical approach, Cancer Treat Rev, 40, 178, 10.1016/j.ctrv.2013.08.002 Eisbruch, 1999, RE-Irradiation of head and neck tumors, Cancer, 13, 825 Lee, 2020, Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: meta-analysis and systematic review, Head Neck, 42, 2473, 10.1002/hed.26264 Langendijk, 2006, A phase II study of primary reirradiation in squamous cell carcinoma of head and neck, Radiother Oncol, 78, 306, 10.1016/j.radonc.2006.02.003 Spencer, 2008, Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck, Head Neck, 30, 281, 10.1002/hed.20697 DAHANCA. Retningslinjer for strålebehandling i DAHANCA-2013. www.dahanca.dk; 2013. Report No.: 4. Skjøtskift, 2018, Dose painting for re-irradiation of head and neck cancer, Acta Oncol, 57, 1693, 10.1080/0284186X.2018.1512753 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 NIH NCI, Division of Cancer Treatment and Diagnosis (DCTD) Common Terminology Criteria for Adverse Events (CTCAE) – EORTC. 2009. Bjordal, 2000, A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group, Eur J Cancer, 36, 1796, 10.1016/S0959-8049(00)00186-6 Osoba, 1997, Current applications of health-related quality-of-life assessment in oncology, Support Care Cancer, 5, 100, 10.1007/BF01262565 Fayers P, Aaronsen N, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. The EORTC QLQ-C30 Scoring Manual (3rd Edition). 2001. Woods, 2022, A Prospective Phase II study of automated non-coplanar VMAT for recurrent head and neck cancer: initial report of feasibility, safety, and patient-reported outcomes, Cancers (Basel), 14, 939, 10.3390/cancers14040939 Vargo, 2014, Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer, Laryngoscope, 124, 1579, 10.1002/lary.24441 Gogineni, 2019, Quality of life outcomes following organ-sparing SBRT in previously irradiated recurrent head and neck cancer, Front Oncol, 9, 10.3389/fonc.2019.00836 Duprez, 2014, High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity, Radiother Oncol, 111, 388, 10.1016/j.radonc.2014.04.018 McDonald, 2012, Risk of carotid blowout after reirradiation of the head and neck: a systematic review, Int J Radiat Oncol Biol Phys, 82, 1083, 10.1016/j.ijrobp.2010.08.029 Xiao, 2015, Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy, PLoS One, 10, e0125351, 10.1371/journal.pone.0125351 Burtness, 2019, Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study, Lancet, 394, 1915, 10.1016/S0140-6736(19)32591-7 Svajdova, 2021, Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: critical review, Head Neck, 43, 354, 10.1002/hed.26485 Ho, 2018, Reirradiation of head and neck cancer using modern highly conformal techniques, Head Neck, 40, 2078, 10.1002/hed.25180 Roesch, 2023, Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis, Radiother Oncol, 181, 109380, 10.1016/j.radonc.2022.10.007 Ward, 2018, Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT Era: a multi-institution cohort study by the MIRI collaborative, Int J Radiat Oncol Biol Phys, 100, 586, 10.1016/j.ijrobp.2017.06.012 Rühle, 2020, The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer, Radiat Oncol, 15, 10.1186/s13014-020-01531-5 Caudell, 2018, Volume, dose, and fractionation considerations for IMRT-based reirradiation in head and neck cancer: a multi-institution analysis, Int J Radiat Oncol Biol Phys, 100, 606, 10.1016/j.ijrobp.2017.11.036 Altay-Langguth, 2021, Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study, Clin Transl Radiat Oncol, 28, 71 Gordon, 2021, Proton re-irradiation of unresectable recurrent head and neck cancers, Rep Pract Oncol Radiother, 26, 203, 10.5603/RPOR.a2021.0029